Navigation Links
Demand for VScan Dengue Fever Test Kits Increases
Date:10/2/2007

EDMONTON, Alberta, Oct. 2 /PRNewswire-FirstCall/ -- Medical Services International Inc. (Pink Sheets: MSITF) is pleased to announce that the demand for its VScan Dengue Fever Kit is increasing. Dengue Fever is spreading across Latin America and the Caribbean in one of the worst outbreaks in decades causing agonizing joint pain for hundreds of thousands of people and killing 200 people so far this year.

This year so far 630,356 cases have been reported in the Americas and with the upcoming rainy season, cases are expected to double. This does not take into account the cases in SE Asia. The danger is that Doctors don't recognize Dengue Fever. There are very few laboratories capable of testing for Dengue Fever, and the ones available take up to 8 weeks to complete the testing. By then it is too late for treatment.

There is no drug for Dengue Fever but early diagnosis resulting in proper treatment including rest, IV fluids and pain relief can reduce death rates to about 1%.

Dengue Fever is mosquito borne and is starting to spread into the southwestern United States.

The VScan Dengue Fever kit gives results in under 20 minutes and is accurate greater than 99% of the time. Early diagnosis with the VScan Dengue Fever kit allows for immediate treatment and reduces the severity and convalescence of the Dengue Fever patient.

Medical Services International Inc. trades in the United States on the NQB Pink Sheets under the symbol "MSITF". For further information, please contact Robert Talbot at (780) 430 6363 or http://www.medicalservicesintl.com or http://www.minerva-biotech.com.

NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies.


'/>"/>
SOURCE Medical Services International Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Avant’s Typhoid Fever Vaccine Demonstrates Excellent Clinical Potential
2. Avants Typhoid Fever Vaccine Demonstrates Excellent Clinical Potential
3. SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193
4. Placebo-controlled Phase IIa Study with the Immunotherapeutic CYT003-QbG10 Shows Significant Improvement of Allergy Symptoms in Hay Fever Patients
5. Rapid HIV Testing Increases Possibility of Treatment
6. ProtoKinetixs AAGP Dramatically Increases Recovery Rate of Cryopreserved Stem Cells
7. Acceleron Pharmas ACE-031 Increases Muscle Mass and Strength in Preclinical Studies
8. MabThera Significantly Increases Survival of Lymphoma Patients Regardless of Chemotherapy Regimen
9. Researchers Discover a Common Variation in a Gene Segment that Increases the Risk for Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that it ... 2017 at the Sheraton Hotel in Toronto, Ontario ... the Company is scheduled to present on Tuesday, May 2 at ... Chairman of the Board, Tony Holler will also attend ... For more details ...
(Date:4/19/2017)... April 19, 2017 Global Surgical Drainage Device ... tubes used to remove excess liquid and air. The ... urine, bile or lymph. Surgical drains are used in ... as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic surgery etc. ... to prevent accumulation of fluid e.g. blood or pus. ...
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
Breaking Medicine Technology:
(Date:4/29/2017)... ... April 29, 2017 , ... ... company, today announced the launch of DonorBridge, its process and engagement analytics ... of software innovation and industry expertise with predictive analytics to help nonprofits ...
(Date:4/29/2017)... ... ... More than half of Americans suffering from noise-induced hearing loss do not ... causes hearing loss? May 1 marks the beginning of Better Hearing & Speech Month—a ... as schedule a hearing evaluation for anyone with concerns about his/her hearing. , Approximately ...
(Date:4/28/2017)... ... April 28, 2017 , ... It's not always common knowledge ... of illnesses that are unclear as to whether or not they are contagious, and ... one of these illnesses. So, FindaTopDoc took a look into the matter. , ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced ... test throughout the Northeast U.S. , GlycoMark is the only clinically available ... test provides a clinically proven one- to two-week measure of hyperglycemic excursions, often ...
(Date:4/28/2017)... ... April 28, 2017 , ... Children ... to more adverse experiences than children in the general population. That’s because foster ... neglect or other family challenges. While no fault of their own, youth who ...
Breaking Medicine News(10 mins):